Observational analysis reveals altered treatment outcomes in patients with HIV and spondyloarthritis, suggesting new clinical approaches.
HIV infection is a very common disease, often associated with other pathologies, in particular rheumatological ones, such as spondyloarthritis. The presence of HIV infection can change the course of spondyloarthritis, and imposes certain limitations on their treatment. At the same time, progress in the treatment of HIV infection and spondyloarthritis has led to a change in the natural course of this combination of diseases and the emergence of new promising approaches to the treatment of patients with HIV and SpA. The presented work systematizes international experience in treating this cohort of patients, taking into account current trends.
No takes yet. Share an insight, caveat, or question.
Shashko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: